First-in-human trial of tocilizumab in combination with a standard induction chemotherapy in newly diagnosed acute myeloid leukemia patients: The phase 1 TOCILAM study. This is an ASCO Meeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results